T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the BRAF V600E Mutation in Papillary Thyroid Carcinoma.

Front Cell Dev Biol · 2020 · PMC7773934 · PMID 33392186

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendp = 0.059so close (0.05 < p ≤ 0.1)

Besides, TBX22 showed a trend in distinguishing between the RET fusion group and the RET wild-type group ( Figure 3D , p = 0.059).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the <i>BRAF</i> <sup><i>V</i>600<i>E</i></sup> Mutation in Papillary Thyroid Carcinoma.

The sentences